The search for a cancer vaccine has largely been a painstaking, systematic chore of isolating some agent that might produce cancer-killing antibodies in human patients. Last week Swedish Immunologist Dr. Bertil Bjorklund announced that he was taking a shortcut. Rather than waiting for time-consuming analysis, he will inoculate humans with a complex substance that has produced favorable cancer antibody responses using rabbits and horses. Over a seven-month period. Bjorklund vaccine will be injected into 100 Swedish volunteers between 60 and 70, an age group of high cancer incidence. At the end of...
To continue reading:
or
Log-In
